KYMR
Kymera Therapeutics Inc
$84.50
-1.27% ($1.09)
Volume
325,590
52W High
$103.00
52W Low
$28.06
Market Cap
$6.65B
Next Earnings Report
Last Reported
Apr 30, 2026 Beat
Actual: -$0.71
vs. Consensus: -$0.82
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
Apr 30, 2026
1-Day:
-0.44%
5-Day:
+2.02%
Q4 2025
Feb 26, 2026
1-Day:
-3.87%
5-Day:
-9.13%
Q4 2025
Feb 19, 2026
1-Day:
+1.04%
5-Day:
+5.21%
Q3 2025
Oct 29, 2025
1-Day:
+2.35%
5-Day:
-0.52%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $2.9M | -61.3% | 2,763.6% | -3,422.9% | -$87.0M |
| Q3'25 | $2.8M | -26.1% | -2,580.7% | -3,347.4% | -$82.2M |
| Q2'25 | $11.5M | -55.3% | 81.8% | -736.8% | -$76.6M |
| Q1'25 | $22.1M | +114.8% | 100.0% | -336.8% | -$65.6M |
| Q4'24 | $7.4M | -84.6% | 100.0% | -1,092.2% | -$70.8M |
| Q3'24 | $3.7M | -20.9% | 100.0% | -1,927.9% | -$62.5M |
| Q2'24 | $25.7M | +55.3% | 100.0% | -198.5% | -$42.1M |
| Q1'24 | $10.3M | +8.7% | 100.0% | -562.2% | -$48.6M |
Company Information
Symbol
KYMR
Company
Kymera Therapeutics Inc
Market Cap
$6.65B